Sequential Anti-PD1 Therapy Following Dendritic Cell Vaccination Improves Survival in a HER2 Mammary Carcinoma Model and Identifies a Critical Role for CD4 T Cells in Mediating the Response. [electronic resource]
Producer: 20201005Description: 1939 p. digitalISSN:- 1664-3224
- Animals
- Antibodies, Monoclonal, Humanized -- immunology
- B7-H1 Antigen -- antagonists & inhibitors
- Breast Neoplasms -- immunology
- CD4-Positive T-Lymphocytes -- drug effects
- Cancer Vaccines -- administration & dosage
- Cell Line, Tumor
- Combined Modality Therapy
- Dendritic Cells -- immunology
- Female
- Humans
- Mammary Neoplasms, Experimental -- immunology
- Mice, Inbred BALB C
- Mice, Transgenic
- Programmed Cell Death 1 Receptor -- antagonists & inhibitors
- Rats
- Receptor, ErbB-2 -- immunology
- Survival Analysis
- Treatment Outcome
- Tumor Burden -- drug effects
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.